HP AND PH - IMPLICATIONS FOR THE ERADICATION OF HELICOBACTER-PYLORI

被引:46
|
作者
HUNT, RH
机构
[1] Division of Gastroenterology, McMaster University Hamilton, Ontario
关键词
AMOXICILLIN; DUODENAL ULCER; ERADICATION; GASTRIC ACID; HELICOBACTER-PYLORI; OMEPRAZOLE; PH;
D O I
10.3109/00365529309098335
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori infection causes inflammation of the gastric and duodenal mucosae, which results in a disturbance of the regulatory mechanisms for gastrin, gastric acid and pepsin secretion. Acid secretion may be decreased, normal or increased, depending on the stage of infection, although the meal-stimulated gastrin response is invariably elevated. The exact mechanisms involved are not known but may be due to the release of cytokines in response to bacterial toxins. H. pylori colonization is reduced by effective acid suppression with proton pump inhibitors, although it is not eradicated. In combination with amoxycillin, omeprazole, up to 40 mg twice daily, eradicated the organism in up to 82% of cases. This synergistic effect may be due to a direct effect of omeprazole on the organism, the protection of amoxycillin from acid degradation, or enhancement of host defence mechanisms accompanying acid suppression.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 50 条
  • [1] ERADICATION OF HELICOBACTER-PYLORI (HP) - A METAANALYSIS
    MOHAMED, H
    CHIBA, N
    WILKINSON, J
    HUNT, R
    GASTROENTEROLOGY, 1994, 106 (04) : A142 - A142
  • [2] WEEKEND THERAPY FOR HELICOBACTER-PYLORI (HP) ERADICATION
    TUCCI, A
    POLI, L
    MAZZONI, C
    PAPARO, GF
    CALETTI, G
    BOCUS, P
    FERRARI, A
    DEGIORGIO, R
    BIASCO, G
    STANGHELLINI, V
    CORINALDESI, R
    GASTROENTEROLOGY, 1995, 108 (04) : A246 - A246
  • [3] PH AND HP - GASTRIC-ACID SECRETION AND HELICOBACTER-PYLORI - IMPLICATIONS FOR ULCER HEALING AND ERADICATION OF THE ORGANISM
    HUNT, RH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1993, 88 (04): : 481 - 483
  • [4] EVALUATION OF THE EFFICACY OF CLARITHROMYCIN IN THE ERADICATION OF HELICOBACTER-PYLORI (HP)
    SPILADIS, C
    GEORGOPOULOS, S
    STAMBOLOS, P
    MENTIS, A
    GIANIKAKI, L
    MANIKA, Z
    SKANDALIS, N
    GASTROENTEROLOGY, 1995, 108 (04) : A225 - A225
  • [5] ERADICATION OF HELICOBACTER-PYLORI - THERAPIES AND CLINICAL IMPLICATIONS
    OCONNOR, HJ
    POSTGRADUATE MEDICAL JOURNAL, 1992, 68 (801) : 549 - 557
  • [6] CLINICAL IMPLICATIONS OF HELICOBACTER-PYLORI ERADICATION - DISCUSSION
    AXON, ATR
    TYTGAT, GNJ
    MALFERTHEINER, P
    DELTENRE, M
    RUNE, SJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 : 48 - 50
  • [7] ERADICATION OF HELICOBACTER-PYLORI
    HARRIS, AW
    MISIEWICZ, JJ
    BAILLIERES CLINICAL GASTROENTEROLOGY, 1995, 9 (03): : 583 - 613
  • [8] ERADICATION OF HELICOBACTER-PYLORI
    OCONNOR, HJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 : S113 - S119
  • [9] HELICOBACTER-PYLORI ERADICATION
    BELL, GD
    POWELL, KU
    PRACTITIONER, 1993, 237 (1525) : 306 - &
  • [10] RELEVANCE OF INVITRO METRONIDAZOLE RESISTANCE TO HELICOBACTER-PYLORI (HP) ERADICATION AND ERADICATION FAILURE
    BORODY, T
    ANDREWS, P
    BRANDL, S
    DEVINE, M
    GASTROENTEROLOGY, 1993, 104 (04) : A44 - A44